{
    "2021-10-01": [
        [
            {
                "time": "2023-10-18",
                "original_text": "Pharma Stock Roundup: MRK to Buy XLRN, ABBV Gets FDA Nod for Migraine Drug & More",
                "features": {
                    "keywords": [
                        "MRK",
                        "XLRN",
                        "ABBV",
                        "FDA",
                        "Migraine Drug"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}